CRXX DD Post ($1.40). Looking for appreciation in price prior to FDA decision on Feb 22nd. If decision is positive I hope to see a strong appreciation in price w/ solid follow through due to share structure and no existing toxic debt.
~The company is debt-free ~18 Million in cash on hand ~ 18 mill/float...35 mill shares/OS....60 mill/Auth ~Deep pipeline. ~Partnership w/ Mallinckrodt (division of COV at $50/share-nasdaq)
Uncertainty for approval lies in whether the questions submitted by the FDA to CRXX were answered to satisfy all the requirements for approval. The FDA extended the deadline from 11/22 to 2/22 in mid-November. High risk/high reward potential.
A lot on the line w/ the possible approval of EXALGO in royalty fees and milestone payments.
Alert: Sold 10,000 shares of CRXX in Starter Portfolio at $1.30. Moving my money to another forward-looking event play. Not sure of FDA approval status. That seems to be reflected in the PPS is my gut feeling. $heff